Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases

Clinica Chimica Acta

Volumn 381, Issue 1, 2007, Pages 21-25

  Fortunato, Giuliana ^a,b   Di Taranto, Maria D ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Atherosclerosis; Candidate gene; Cardiovascular disease; Gene expression; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL ESTER TRANSFER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; LEUKOTRIENE A4 HYDROLASE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; MANGANESE SUPEROXIDE DISMUTASE; STROMELYSIN;

ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CELL MIGRATION; DISEASE COURSE; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPID OXIDATION; MICROARRAY ANALYSIS; MORTALITY; NORTHERN BLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; ENZYMES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; POLYMORPHISM, GENETIC;

EID: 34248203795     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.018     Document Type: Review

References (57)

1. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis: part II: clinical implications. Circulation 110 (2004) 2066-2071
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
3. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 110 (2004) 1868-1873
4. Watkins H., and Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 7 (2006) 163-173
5. Voetsch B., and Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 24 (2004) 216-229
6. Puddu P., Cravero E., Puddu G.M., and Muscari A. Genes and atherosclerosis: at the origin of the predisposition. Int J Clin Pract 59 (2005) 462-472
7. Kakko S., Tamminen M., Paivansalo M., et al. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur J Clin Investig 30 (2000) 18-25
8. Pallaud C., Sass C., Zannad F., Siest G., and Visvikis S. APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 59 (2001) 316-324
9. Rundek T., Elkind M.S., Pittman J., et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33 (2002) 1420-1423
10. Rauramaa R., Vaisanen S.B., Luong L.A., et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 2657-2662
11. Flex A., Gaetani E., Papaleo P., et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35 (2004) 2270-2275
12. Baum L., Ng H.K., Wong K.S., et al. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction. Clin Chem Lab Med 44 (2006) 274-281
13. van Bockxmeer F.M., Liu Q., Mamotte C., Burke V., and Taylor R. Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 157 (2001) 123-129
14. Morrison A.C., Ballantyne C.M., Bray M., Chambless L.E., Sharrett A.R., and Boerwinkle E. LPL polymorphism predicts stroke risk in men. Genet Epidemiol 22 (2002) 233-242
15. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
16. Yang Z., and Ming X.F. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 4 (2006) 53-65
17. Kakko S., Paivansalo M., Koistinen P., Kesaniemi Y.A., Kinnula V.L., and Savolainen M.J. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 168 (2003) 147-152
18. Leus F.R., Wittekoek M.E., Prins J., Kastelein J.J., and Voorbij H.A. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 149 (2000) 371-377
19. Malin R., Loimaala A., Nenonen A., et al. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism 50 (2001) 1095-1101
20. Voetsch B., Benke K.S., Damasceno B.P., Siqueira L.H., and Loscalzo J. Paraoxonase 192 GlnArg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 33 (2002) 1459-1464
21. Sanghera D.K., Aston C.E., Saha N., and Kamboh M.I. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 62 (1998) 36-55
22. Martinelli N., Girelli D., Olivieri O., et al. Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Investig 34 (2004) 14-20
23. Dwyer J.H., Allayee H., Dwyer K.M., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350 (2004) 29-37
24. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
25. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
26. Lim P.S., Hung W.R., and Wei Y.H. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron 87 (2001) 249-256
27. Kawamoto R., Kohara K., Tabara Y., et al. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J Hum Genet 46 (2001) 506-510
28. Inamoto N., Katsuya T., Kokubo Y., et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 34 (2003) 1628-1633
29. Passaro A., Vanini A., Calzoni F., et al. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157 (2001) 175-180
30. Li Z., Sun L., Zhang H., et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34 (2003) 2085-2090
31. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
32. Hosoi M., Nishizawa Y., Kogawa K., et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 94 (1996) 704-707
33. Kauma H., Paivansalo M., Savolainen M.J., et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 14 (1996) 1183-1187
34. Sayed-Tabatabaei F.A., Schut A.F., Hofman A., et al. A study of gene-environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet 41 (2004) 99-103
35. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 64 (1998) 227-230
36. Peters-Golden M., and Brock T.G. 5-Lipoxygenase and FLAP. Prostaglandins Leukot Essent Fat Acids 69 (2003) 99-109
37. Lotzer K., Funk C.D., and Habenicht A.J. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 1736 (2005) 30-37
38. Ng C.J., Shih D.M., Hama S.Y., Villa N., Navab M., and Reddy S.T. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 38 (2005) 153-163
39. Fortunato G., Rubba P., Panico S., et al. A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis 167 (2003) 141-148
40. Erlich P.M., Lunetta K.L., Cupples L.A., et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet 15 (2006) 77-85
41. Carmine A., Buervenich S., Sydow O., Anvret M., and Olson L. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease. Mov Disord 17 (2002) 764-766
42. Fortunato G., Marciano E., Zarrilli F., et al. Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss. Clin Chem 50 (2004) 2012-2018
43. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143-149
44. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 245 (1997) 154-160
45. Casas J.P., Hingorani A.D., Bautista L.E., and Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61 (2004) 1652-1661
46. Mackness B., Davies G.K., Turkie W., et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?. Arterioscler Thromb Vasc Biol 21 (2001) 1451-1457
47. Wheeler J.G., Keavney B.D., Watkins H., Collins R., and Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 363 (2004) 689-695
48. Lawlor D.A., Day I.N., Gaunt T.R., et al. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet 23 5 (2004) 17
49. Yang Q., Khoury M.J., Botto L., Friedman J.M., and Flanders W.D. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 72 (2003) 636-649
50. Nanni L., Romualdi C., Maseri A., and Lanfranchi G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol 41 (2006) 934-948
51. Tuomisto T.T., Korkeela A., Rutanen J., et al. Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array: overexpression of HMG-CoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and interleukin receptors. Arterioscler Thromb Vasc Biol 23 (2003) 2235-2240
52. Woodside K.J., Hernandez A., Smith F.W., et al. Differential gene expression in primary and recurrent carotid stenosis. Biochem Biophys Res Commun 302 (2003) 509-514
53. Haley K.J., Lilly C.M., Yang J.H., et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102 (2000) 2185-2189
54. Qiu H., Gabrielsen A., Agardh H.E., et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 103 (2006) 8161-8166
55. Cipollone F., Mezzetti A., Fazia M.L., et al. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 25 (2005) 1665-1670
56. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A 100 (2003) 1238-1243
57. Jones C.B., Sane D.C., and Herrington D.M. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 59 (2003) 812-823